JESSICA HUNNICUTT: Open Payments
NPI 1215315452 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,783 in 110 payments from 12 companies in 2025. Trend: 2023 $1,661 · 2024 $1,677 · 2025 $1,783
Food & beverage: $1,783
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $378 |
| ABBVIE INC. | 24 | $319 |
| Alkermes, Inc. | 12 | $231 |
| Otsuka America Pharmaceutical, Inc. | 9 | $172 |
| Neurocrine BioSciences, Inc. | 10 | $168 |
| Axsome Therapeutics, Inc. | 8 | $163 |
| Vanda Pharmaceuticals Inc. | 7 | $137 |
| Janssen Pharmaceuticals, Inc | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Lundbeck LLC | 1 | $33 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, Auvelity, ARISTADA, ABILIFY ASIMTUFII, FANAPT, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
